Fetal tissue transplantation, bone marrow transplantation and prospective gene therapy in severe immunodeficiencies and enzyme deficiencies
- 1 January 1987
- book chapter
- Published by Springer Nature
- Vol. 10, 75-87
- https://doi.org/10.1007/978-94-009-3365-1_8
Abstract
The successful development of fetal tissue transplantation has resulted in therapeutical solutions for patients with a variety of diseases. Fetal liver transplants as well as bone marrow transplants, can completely cure patients with severe combined immunodeficiency disease. These transplants can also be applied to treat other types of immunodeficiency, hemopathies, and inborn errors of metabolism, in association with immunosuppressive therapy. Despite complete HLA incompatibility between transplanted stem cells and host cells, functional activities of donor-derived T-lymphocytes are not restricted. In severe forms of Di George syndrome, immunological reconstitution can be obtained by fetal thymus transplantation. It is expected that, in the near future, pure stem cell transplants and gene transplants will develop and will provide remarkable solutions for the therapy of a large number of diseases.Keywords
This publication has 16 references indexed in Scilit:
- BONE-MARROW TRANSPLANTATION FOR IMMUNODEFICIENCIES AND OSTEOPETROSIS: EUROPEAN SURVEY, 1968-1985The Lancet, 1986
- Cooperation between major histocompatibility complex mismatched mononuclear cells from a human chimera in the production of antigen-specific antibody.Journal of Clinical Investigation, 1986
- TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLSThe Lancet, 1981
- Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemiaJAMA, 1981
- Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.The Journal of Experimental Medicine, 1979
- Severe combined immunodeficiency disease. Characterization of the disease and results of transplantationJAMA, 1977
- Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiencyProceedings of the National Academy of Sciences, 1977
- TRANSPLANTATION OF BONE-MARROW CELLS AND FETAL THYMUS IN AN INFANT WITH LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1969
- Graft versus Host Inhibition: Fetal Liver and Thymus Cells to Minimize Secondary DiseaseScience, 1969
- IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1968